In laboratory and animal studies, GLP-1 receptor agonists appear to reduce production of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
More serious but less common risks include pancreatitis, gallbladder disease, acute kidney injury (particularly in the setting of dehydration from gastrointestinal symptoms), and hypoglycemia when used in combination with insulin or sulfonylureas
We considered the following differential diagnoses: malignant disorders, drug-induced injury by bisphosphonates and dabigatran etexilate methanesulfonate, viral infection by cytomegalovirus and herpesviruses, and severe gastro-oesophageal reflux disease (GERD)
Semaglutide is approved by the FDA, and countless people have begun to use this fantastic injectable for their weight loss journeys
Human trials evaluating tesofensine for weight loss have also reported a reduction in alcohol intake among participants, indicating a potential indirect effect on alcohol addiction
Ozempic 0.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC)